Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma

dihydroergotamine mesylate injection - Generic mfg.

dihydroergotamine mesylate DPI (ASY202) - Aspeya

Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma (clinicaltrials.gov) - Jun 25, 2026 - P1 | N=40 | Recruiting | Sponsor: Aspeya, Inc.
New P1 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

http://clinicaltrials.gov/ct2/show/NCT07665892

Jun 25, 2026